🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New guideline for the treatment of axial spondyloarthritis 📄 This BSR guideline was co-chaired and co-first authored by Dr Steven Zhao (Steven Zhao) from our Rheumatic and Musculoskeletal Diseases Theme 👇

⏳ Time is running out! Only one week left to register for the #CRFBRC25 conference - don't miss this opportunity to be part of a one of a kind event, bringing together the UK experimental medicine infrastructure. Register by 12 June: ukcrfnetwork.co.uk/events/ukcrf-n… UKCRF Network

🧬 A breakthrough by MFT NHS and UoM Biology, Medicine and Health researchers could provide a genetic explanation for thousands of people with neurodevelopmental conditions. This paves the way for improved diagnosis and opens new doors for future treatments. Read more 👇 research.cmft.nhs.uk/news-events/ma…

MFT NHS UoM Biology, Medicine and Health Adam Jackson Siddharth Banka NIHR Manchester Biomedical Research Centre National Institute for Health and Care Research Sarah Wynn Genomics England Murdoch Children's Research Institute (MCRI) A precise diagnosis for 18-year-old Rose's seizures and developmental delay had proved difficult to find. Thanks to this research, Rose, from Stretford in Manchester, received a diagnosis of one of the newly discovered conditions last year. 👇 research.cmft.nhs.uk/news-events/ma…

Today we are celebrating Professor Gareth Evans' outstanding career & achievements. Gareth has established a national & international reputation in clinical & research aspects of cancer genetics, particularly in breast & ovarian cancer predisposition and neurofibromatosis.

“This research study which has discovered two new frequent causes of neurodevelopmental conditions is incredibly important and valuable to patients and families, who have often been searching for a long time for the answer to their child’s developmental delays." - Sarah Wynn

The paper ‘Analysis of R-loop forming regions identifies RNU2-2 and RNU5B-1 as neurodevelopmental disorder genes’ is available Open Access from this link 👇🏼 nature.com/articles/s4158…

🚨 Exciting news - we've extended the registration deadline for the #CRFBRC25 conference! You now have until 27 June to secure your ticket & join us for an incredible event filled with networking, cutting-edge research, and expert insights. Don't miss out! ukcrfnetwork.co.uk/events/ukcrf-n…

🧬 One of these three new pieces of research which uncovered two new genetic disorders comes from a study delivered through Manchester BRC. The team analysed the genetic data from thousands of patients and participants. Read more on our website 👇 manchesterbrc.nihr.ac.uk/news-and-event…

Today was our Healthcare Professional Showcase Event for nurses, midwives, allied health professionals and other healthcare professionals from our partner NHS Trusts 🏥 Attendees heard inspiring career journeys from those who work with us and gained insights into BRC research.

Researchers have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia. This work was supported by Dr Maria Jakobsdottir and Professor David Wedge from Manchester BRC’s Next Generation Phenotyping and Diagnostics Theme 👇

💬This week, Dr Bruno Simões from Manchester BRC presented a poster at the Gordon Research Conference on Mammary Gland Biology in Maine, USA He shared study findings which suggest that blocking the progesterone receptor could be a promising strategy for breast cancer prevention.

💬 Manchester BRC researchers Prof Clare Murray and Prof Angela Simpson and NIHR PhD Primary Care Research student, Hannah Wardman, presented new findings at the EAACI Congress in Glasgow. This work is helping to shape the future of allergy prevention and respiratory health.